» Articles » PMID: 21821918

Reduction of ER Stress Via a Chemical Chaperone Prevents Disease Phenotypes in a Mouse Model of Primary Open Angle Glaucoma

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2011 Aug 9
PMID 21821918
Citations 182
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in myocilin (MYOC) are the most common genetic cause of primary open angle glaucoma (POAG), but the mechanisms underlying MYOC-associated glaucoma are not fully understood. Here, we report the development of a transgenic mouse model of POAG caused by the Y437H MYOC mutation; the mice are referred to herein as Tg-MYOC(Y437H) mice. Analysis of adult Tg-MYOC(Y437H) mice, which we showed express human MYOC containing the Y437H mutation within relevant eye tissues, revealed that they display glaucoma phenotypes (i.e., elevated intraocular pressure [IOP], retinal ganglion cell death, and axonal degeneration) closely resembling those seen in patients with POAG caused by the Y437H MYOC mutation. Mutant myocilin was not secreted into the aqueous humor but accumulated in the ER of the trabecular meshwork (TM), thereby inducing ER stress in the TM of Tg-MYOC(Y437H) mice. Furthermore, chronic and persistent ER stress was found to be associated with TM cell death and elevation of IOP in Tg-MYOC(Y437H) mice. Reduction of ER stress with a chemical chaperone, phenylbutyric acid (PBA), prevented glaucoma phenotypes in Tg-MYOC(Y437H) mice by promoting the secretion of mutant myocilin in the aqueous humor and by decreasing intracellular accumulation of myocilin in the ER, thus preventing TM cell death. These results demonstrate that ER stress is linked to the pathogenesis of POAG and may be a target for treatment in human patients.

Citing Articles

Does Age Modify the Relation Between Genetic Predisposition to Glaucoma and Various Glaucoma Traits in the UK Biobank?.

Kim J, Kang J, Wiggs J, Zhao H, Li K, Zebardast N Invest Ophthalmol Vis Sci. 2025; 66(2):57.

PMID: 39982391 PMC: 11855177. DOI: 10.1167/iovs.66.2.57.


Extracellular vesicles as emerging players in glaucoma: Mechanisms, biomarkers, and therapeutic targets.

Namdari M, McDonnell F Vision Res. 2024; 226:108522.

PMID: 39581065 PMC: 11640964. DOI: 10.1016/j.visres.2024.108522.


Gene therapy for glaucoma: Targeting key mechanisms.

Henderson J, OCallaghan J, Campbell M Vision Res. 2024; 225:108502.

PMID: 39423611 PMC: 11579448. DOI: 10.1016/j.visres.2024.108502.


Differential Retinal Ganglion Cell Vulnerability, A Critical Clue for the Identification of Neuroprotective Genes in Glaucoma.

Amin D, Kuwajima T Front Ophthalmol (Lausanne). 2024; 2:905352.

PMID: 38983528 PMC: 11182220. DOI: 10.3389/fopht.2022.905352.


Profiling IOP-Responsive Genes in the Trabecular Meshwork and Optic Nerve Head in a Rat Model of Controlled Elevation of Intraocular Pressure.

Lozano D, Yang Y, Cepurna W, Smoody B, Ing E, Morrison J Invest Ophthalmol Vis Sci. 2024; 65(5):41.

PMID: 38809543 PMC: 11146053. DOI: 10.1167/iovs.65.5.41.


References
1.
Lively G, Koehn D, Hedberg-Buenz A, Wang K, Anderson M . Quantitative trait loci associated with murine central corneal thickness. Physiol Genomics. 2010; 42(2):281-6. PMC: 3032283. DOI: 10.1152/physiolgenomics.00140.2009. View

2.
Kim C, Kuehn M, Anderson M, Kwon Y . Intraocular pressure measurement in mice: a comparison between Goldmann and rebound tonometry. Eye (Lond). 2006; 21(9):1202-9. DOI: 10.1038/sj.eye.6702576. View

3.
Shepard A, Jacobson N, Millar J, Pang I, Steely H, Searby C . Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum Mol Genet. 2007; 16(6):609-17. DOI: 10.1093/hmg/ddm001. View

4.
Morissette J, Clepet C, Moisan S, Dubois S, Winstall E, Vermeeren D . Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma. Nat Genet. 1998; 19(4):319-21. DOI: 10.1038/1203. View

5.
Trantow C, Mao M, Petersen G, Alward E, Alward W, Fingert J . Lyst mutation in mice recapitulates iris defects of human exfoliation syndrome. Invest Ophthalmol Vis Sci. 2008; 50(3):1205-14. PMC: 2693230. DOI: 10.1167/iovs.08-2791. View